BACKGROUND: We aimed to demonstrate that MYC amplification in adenocarcinomas of the stomach (GC) and gastroesophageal junction (GEJ) is of tumor biological significance and exhibits intratumoral heterogeneity. This evidence concerns the gene MYC and gastric adenocarcinoma.